Pharma Aids Limited (DSE: PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 720.20
+15.20 (2.16%)
At close: Sep 12, 2024
Pharma Aids Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 11, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Market Capitalization | 2,247 | 2,467 | 2,543 | 1,241 | 1,273 | 1,896 | Upgrade
|
| Market Cap Growth | -19.65% | -2.98% | 104.83% | -2.50% | -32.83% | -11.76% | Upgrade
|
| Enterprise Value | 2,201 | 2,459 | 2,502 | 1,228 | 1,278 | 1,911 | Upgrade
|
| Last Close Price | 720.20 | 789.70 | 808.82 | 391.09 | 396.52 | 584.05 | Upgrade
|
| PE Ratio | 44.27 | -386.02 | 72.59 | 24.28 | 23.58 | 37.72 | Upgrade
|
| PS Ratio | 5.49 | 8.00 | 7.87 | 4.43 | 4.72 | 7.61 | Upgrade
|
| PB Ratio | 6.63 | 8.66 | 8.25 | 4.27 | 4.94 | 8.55 | Upgrade
|
| P/FCF Ratio | 80.50 | 487.65 | 87.24 | 58.77 | 35.68 | 81.35 | Upgrade
|
| P/OCF Ratio | 66.02 | 339.47 | 75.13 | 39.53 | 31.29 | 75.51 | Upgrade
|
| EV/Sales Ratio | 5.38 | 7.97 | 7.74 | 4.38 | 4.74 | 7.67 | Upgrade
|
| EV/EBITDA Ratio | 26.42 | 134.45 | 40.46 | 16.47 | 15.90 | 25.45 | Upgrade
|
| EV/EBIT Ratio | 28.89 | 230.56 | 46.32 | 18.52 | 17.80 | 29.03 | Upgrade
|
| EV/FCF Ratio | 78.84 | 485.99 | 85.84 | 58.15 | 35.82 | 82.02 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.04 | 0.00 | 0.00 | 0.02 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.63 | 0.02 | 0.00 | 0.06 | 0.20 | Upgrade
|
| Debt / FCF Ratio | 0.14 | 2.27 | 0.03 | 0.01 | 0.14 | 0.64 | Upgrade
|
| Asset Turnover | 0.97 | 0.81 | 0.89 | 0.85 | 0.90 | 0.91 | Upgrade
|
| Inventory Turnover | 5.39 | 4.27 | 4.26 | 5.48 | 5.13 | 4.70 | Upgrade
|
| Quick Ratio | 1.95 | 1.77 | 2.50 | 3.47 | 3.29 | 2.23 | Upgrade
|
| Current Ratio | 3.36 | 3.26 | 4.32 | 5.17 | 4.17 | 3.22 | Upgrade
|
| Return on Equity (ROE) | 16.10% | -2.15% | 11.60% | 18.32% | 21.89% | 23.48% | Upgrade
|
| Return on Assets (ROA) | 11.26% | 1.75% | 9.35% | 12.60% | 14.93% | 15.08% | Upgrade
|
| Return on Capital (ROIC) | 14.58% | 2.20% | 11.24% | 14.97% | 17.98% | 18.38% | Upgrade
|
| Earnings Yield | 2.26% | -0.26% | 1.37% | 4.05% | 4.12% | 2.55% | Upgrade
|
| FCF Yield | 1.24% | 0.21% | 1.15% | 1.70% | 2.80% | 1.23% | Upgrade
|
| Dividend Yield | 0.14% | 0.13% | 0.62% | 1.28% | 1.26% | 0.86% | Upgrade
|
| Payout Ratio | 9.15% | - | 72.69% | 29.94% | 36.04% | 32.29% | Upgrade
|
| Total Shareholder Return | 0.14% | 0.13% | 0.62% | 1.28% | 1.26% | 0.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.